Comparison of different brands of IVIg in an in vitro model of immune neuropathy

Gang Zhang, Pablo H.H. Lopez, Kazim A. Sheikh

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Intravenous immunoglobulin (IVIg) is used for the treatment of a number of autoimmune neurological disorders. Whether different brands of IVIg or different lots of the same brand are comparably efficacious for the treatment of neurological disorders is not clear. To examine this issue we compared the efficacy of different brands and/or lots of IVIg in a cell culture model of immune neuropathy. We report that products examined were equally effective and there was no lot-to-lot variability in our experimental model. These findings support the notion that efficacy of different IVIg products is comparable in a standardized model.

Original languageEnglish (US)
Pages (from-to)200-203
Number of pages4
JournalJournal of Neuroimmunology
Issue number1-2
StatePublished - Apr 2006


  • CIDP
  • Guillain-Barré syndrome
  • IVIg
  • Immune neuropathies
  • Peripheral neuropathies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Comparison of different brands of IVIg in an in vitro model of immune neuropathy'. Together they form a unique fingerprint.

Cite this